A First-in-Human Study of RPT193 in Healthy Volunteers and Patients With Atopic Dermatitis

Clinical trial NCT04271514 · COMPLETED

Trial details

NCT number: NCT04271514
Sponsor: RAPT Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2019-08-12
Primary completion: 2021-04-26
Enrollment: 103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.